A study released by researchers on 9/3/14 suggests that selective serotonin reuptake inhibitors (SSRIs) like Celexa, Lexapro, Zoloft, Prozac, and Paxil, may be associated with a greater incidence of bone loss or lack of bone formation in patients who use those drugs. This, in turn, motivated researchers to evaluate the potential for dental implant failure in patients taking SSRIs.
But the debate is significant. In fact, a response released on 9/5/14 regarding a comprehensive study of SSRIs and bone fracture was recently released. This statement illustrates how SSRis were not responsible for a significantly greater risk for bone loss or bone fractures in a larger study population; the incidence of bone loss or lack of bone formation was due in larger part to factors such as smoking, alcohol, lack of calcium and vitamin D, among others.
At this point, it seems that the risk for dental implant failure remains reasonably low for patients taking SSRIs. But the other issues surrounding bone health are still an important consideration when doctors are planning dental implant care for their patients.
Chris Rafoth is the owner of Lyons Creek Dental Care, providing medical dentistry, dental implants, and facial esthetics since 1998 for Shoreline and greater Seattle areas, as well as communities in King and Snohomish counties. Any questions or comments? Contact him at chris@lyonscreekdentalcare.com today!
